Search details
1.
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.
Br J Cancer
; 126(12): 1783-1794, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35177798
2.
Cancer patient perspective in the arena of COVID-19 pandemic.
Psychooncology
; 31(1): 39-45, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34315188
3.
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
Acta Oncol
; 60(10): 1317-1324, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34282710
4.
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
Int J Mol Sci
; 20(6)2019 Mar 26.
Article
in English
| MEDLINE | ID: mdl-30917505
5.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Article
in English
| MEDLINE | ID: mdl-30130791
6.
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.
Gastric Cancer
; 20(1): 156-163, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-26796888
7.
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
Dig Dis Sci
; 62(8): 1872-1880, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28527050
8.
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.
BMC Cancer
; 16: 429, 2016 07 07.
Article
in English
| MEDLINE | ID: mdl-27388325
9.
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.
J Transl Med
; 13: 140, 2015 May 07.
Article
in English
| MEDLINE | ID: mdl-25943333
10.
[Treatment of pancreatic cancer. Actuality and perspective]. / Trattamento del carcinoma del pancreas. Attualità e prospettive.
Recenti Prog Med
; 106(5): 208-16, 2015 May.
Article
in Italian
| MEDLINE | ID: mdl-25994537
11.
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Int J Cancer
; 135(5): 1247-56, 2014 Sep 01.
Article
in English
| MEDLINE | ID: mdl-24510746
12.
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management.
BMC Cancer
; 14: 110, 2014 Feb 20.
Article
in English
| MEDLINE | ID: mdl-24552144
13.
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.
Future Oncol
; 10(14): 2103-6, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25471023
14.
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
Molecules
; 19(5): 6393-406, 2014 May 19.
Article
in English
| MEDLINE | ID: mdl-24853455
15.
Role of ß4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab.
Future Oncol
; 9(8): 1207-14, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23617461
16.
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy.
Front Oncol
; 13: 1128930, 2023.
Article
in English
| MEDLINE | ID: mdl-37091141
17.
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.
J Transl Med
; 10: 71, 2012 Apr 10.
Article
in English
| MEDLINE | ID: mdl-22490361
18.
Selecting the best treatment for an individual patient.
Recent Results Cancer Res
; 196: 307-18, 2012.
Article
in English
| MEDLINE | ID: mdl-23129382
19.
The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.
Crit Rev Oncol Hematol
; 170: 103596, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35031442
20.
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
J Chemother
; 34(8): 543-549, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35156913